NCT06685081View on ClinicalTrials.gov

Dexmedetomidine for Improved Pain Relief and Recovery in Spine Surgery

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 15, 2024

Study Completion Date

November 1, 2024

Conditions
Pain, Postoperative
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine was injected in dose of 0.25 µg/kg

DRUG

Dexmedetomidine

Dexmedetomidine was injected in dose of 0.5 µg/kg

DRUG

Dexmedetomidine

Dexmedetomidine was injected in dose of 0.75 µg/kg

DRUG

Dexmedetomidine

Dexmedetomidine was injected in dose of 1 µg/kg

DRUG

lidocaine and triamcinolone

2 ml of 1.5% lidocaine and 2 ml of triamcinolone was mixed and provided to all patients as epidural injection

Trial Locations (1)

13511

Menoufia University, Shibīn al Kawm

All Listed Sponsors
lead

Menoufia University

OTHER

NCT06685081 - Dexmedetomidine for Improved Pain Relief and Recovery in Spine Surgery | Biotech Hunter | Biotech Hunter